Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Agrium Inc.’s (AGU - Analyst Report) fourth-quarter 2012 adjusted (excluding one-time items) earnings from continuing operations of $2.16 per share handily beat the Zacks Consensus Estimate of $2.02.
Profit, as reported, grew 83% year over year to $354 million (or $2.34 per share) from $193 million (or $1.20 per share) a year ago, helped by higher sales of the Canada-based fertilizer company’s crop protection products and crop nutrients. An extended fall season in the U.S. boosted the demand for its nutrients in the quarter. Agrium recorded a loss of $134 million from discontinued operations in the year-ago quarter.
For full-year 2012, reported profit climbed 9% year over year to $1,498 million or $9.55 per share. Adjusted earnings of $9.75 per share surpassed the Zacks Consensus Estimate of $9.21.
Revenues rose roughly 3% year over year to $3,261 million in the reported quarter, also beating the Zacks Consensus Estimate of $3,116 million. Higher sales in the Retail segment were partly offset by a decline in the Wholesale division.
For the full year, sales climbed 8% year over year to $16,686 million, beating the Zacks Consensus Estimate of $16,493 million.
Segment Highlights
Revenues from the Retail segment rose 8% year over year to $2 billion in the fourth quarter as favorable weather conditions and greater winter wheat plantation led to higher sales of crop protection products and crop nutrients. The company witnessed higher sales from crop nutrient (up 6%), crop protection (up 22%) and seed (up 27%) in the quarter. Segment gross profit jumped 13% year over year to a record $509 million.
The Wholesale segment sales fell 5% year over year to $1.4 billion in the quarter. Gross profit fell 12% to $490 million. The results were impacted by weak potash demand globally and weaker phosphate pricing. Nitrogen sales volume rose 6% on the back of strong domestic and international urea demand.
Potash sales volume, however, dipped 14% in the quarter as lower demand and weak pricing hurt international volumes in the quarter, offsetting a healthy increase in domestic volumes. Phosphate volume also fell 2% in the quarter.
Revenues from the Advanced Technologies division fell 4% to $140 million. Gross profit declined 13% to $33 million, impacted by new arrangements with former joint venture partners.
Financial Position
Agrium exited 2012 with cash and cash equivalents of roughly $726 million, down nearly 46% year over year. Long-term debt increased 24% year over year to $2.6 billion.
Outlook
Moving ahead, the company expects tight grain and oilseed supply to aid crop pricing in first-half 2013. It also sees higher acreage of major field crops across North America and international markets in 2013. Attractive crop nutrient prices are expected to lead to strong crop input demand.
The demand outlook for potash is favorable for the first half this year. Higher potash imports are expected in China and Brazil. However, the demand environment is expected to remain weak in India. The company expects higher potash demand in the U.S. based on high crop acreage and prices. Global potash shipments are expected to increase to between 55 million and 57 million tons this year from roughly 52 million tons in 2012.
On the phosphate front, the company does not see significant demand from India (a major phosphate import market) in first-quarter 2013. The global pricing environment is expected to remain weak.
Agrium, which is among the prominent fertilizer companies along with CF Industries (CF - Analyst Report), Mosaic (MOS - Snapshot Report) and Potash Corp. (POT - Analyst Report), stands to gain from rising crop prices and overall strong fundamentals for the agriculture and crop input market.
The company follows a strategy to grow along the value chain through a combination of acquisitions and organic development. The acquisition of AWB Limited has expanded Agrium’s Retail division and provided access to the growing Southeast Asia market.
Agrium currently retains a Zacks Rank #3 (Hold).
Get the full Analyst Report on POT - FREE
Get the full Analyst Report on CF - FREE
Get the full Analyst Report on AGU - FREE
Get the full Snapshot Report on MOS - FREE